There is a need to minimize oral corticosteroid (OCS) use in patients with asthma to prevent their costly and burdensome adverse effects. Current guidelines do not provide recommendations for OCS tapering in patients with asthma. The objective of this paper was to develop an expert consensus on OCS tapering among international experts.

Read the publication: https://www.atsjournals.org/doi/10.1164/rccm.202007-2721OC